Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Neurometrix Inc (NURO) USD0.0001

Sell:$0.26 Buy:$0.41 Change: $0.0164 (5.77%)
NASDAQ:0.04%
Market closed |  Prices as at close on 14 November 2019 | Switch to live prices |
Sell:$0.26
Buy:$0.41
Change: $0.0164 (5.77%)
Market closed |  Prices as at close on 14 November 2019 | Switch to live prices |
Sell:$0.26
Buy:$0.41
Change: $0.0164 (5.77%)
Market closed |  Prices as at close on 14 November 2019 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

NeuroMetrix, Inc. is a healthcare company combining bioelectrical and digital medicine to address chronic health conditions, including chronic pain, sleep disorders and diabetes. The Company is engaged in the sale of medical equipment, and consumables and accessories. It has two principal product lines: Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. Its products include ADVANCE NCS/EMG System (the ADVANCE System), Quell, SENSUS and DPNCheck. Quell is a wearable device for relief of chronic intractable pain, such as nerve pain due to diabetes and lower back problems. The SENSUS pain therapy device, the technological predecessor to Quell, is a prescription neuro-stimulation device based on transcutaneous electrical nerve stimulation (TENS) for relief of chronic, intractable pain. DPNCheck is a quantitative nerve conduction test. ADVANCE System is a platform for the performance of traditional nerve conduction studies.

Contact details

Address:
1000 Winter St
WALTHAM
02451-1436
United States
Telephone:
+1 (781) 8909989
Website:
www.neurometrix.com

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
NURO
ISIN:
US6412557083
Market cap:
$2.74 million
Shares in issue:
9.78 million
Sector:
Health Care Equipment
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • Shai Gozani
    Chairman of the Board, President, Chief Executive Officer, Secretary, Director
  • Thomas Higgins
    Chief Financial Officer, Senior Vice President, Treasurer
  • Francis McGillin
    Senior Vice President, Chief Commercial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.